Journals / Journal of Medicine and Palliative Care / 2026 / Volume: 7 Issue: 4

Comprehensive assessment of hematologic inflammatory indices across all trimesters in intrahepatic cholestasis of pregnancy

Zübeyde Emiralioğlu Çakır(Buca Seyfi Demirsoy Education and Research Hospital)0000-0001-8298-8363
Dilara Ekici Zincirci(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL OKMEYDANI SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0001-7702-0227
Raziye Torun(Buca Seyfi Demirsoy Education and Research Hospital)0000-0002-0272-7196
Pages
—
Publication Date
2026-08-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Elevated first-trimester NLR and SII and increased third-trimester MPV may reflect gestational stage-dependent immune activation; however, their overall discriminative performance remains limited.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: To evaluate trimester-specific changes in hematologic inflammatory indices in pregnancies complicated by intrahepatic cholestasis of pregnancy (ICP) and to determine their potential discriminative performance.
📊
Key Findings & Data:Methods: This retrospective case–control study included 84 pregnancies with ICP and 96 healthy controls.
💡
Conclusion & Impact:Elevated first-trimester NLR and SII and increased third-trimester MPV may reflect gestational stage-dependent immune activation; however, their overall discriminative performance remains limited.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Intrahepatic cholestasis of pregnancy · neutrophil-to-lymphocyte ratio · Systemic Immune-inflammation Index

Abstract

Aims: To evaluate trimester-specific changes in hematologic inflammatory indices in pregnancies complicated by intrahepatic cholestasis of pregnancy (ICP) and to determine their potential discriminative performance. Methods: This retrospective case–control study included 84 pregnancies with ICP and 96 healthy controls. Complete blood count parameters obtained in each trimester were used to calculate neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), Systemic Immune-inflammation Index (SII), Systemic Inflammation Response Index (SIRI), pan-immune-inflammation value (PIV), and mean platelet volume (MPV). Groups were compared using appropriate statistical tests. Receiver operating characteristic (ROC) analysis was performed to assess the discriminatory performance of first-trimester indices. Results: Third-trimester body mass index, gestational age at delivery, and birth weight differed significantly between groups (p≤0.001). In trimester-based comparisons, first-trimester neutrophil count, platelet count, NLR, and SII were significantly higher in the ICP group (p=0.042; p=0.011; p=0.005; and p=0.028, respectively). Second-trimester hemoglobin and neutrophil counts were modestly increased in ICP (p=0.038 and p=0.022). In the third trimester, only MPV was significantly elevated in the ICP group (p<0.001). ROC analysis demonstrated modest discriminatory ability for first-trimester NLR (AUC=0.621; p=0.005) and SII (AUC=0.595; p=0.028), whereas other indices were not significant. Conclusion: Selected inflammatory indices demonstrate trimester-specific associations with ICP. Elevated first-trimester NLR and SII and increased third-trimester MPV may reflect gestational stage-dependent immune activation; however, their overall discriminative performance remains limited. These markers may serve as supportive but not standalone diagnostic tools.

🔖

Cite This Article

Çakır, Z. E., Ömeroğlu, İ., Zincirci, D. E., Arzık, İ. G., Torun, R., Özdoğan, B. C., Livdumlu, H. B., Gölbaşı, H. (2026). Comprehensive assessment of hematologic inflammatory indices across all trimesters in intrahepatic cholestasis of pregnancy. Journal of Medicine and Palliative Care, Volume: 7 Issue: 4. https://doi.org/10.47582/jompac.1964297

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (34)

  1. Çallıoğlu N, Tuna G, Tandoğan Ö, Ersan F, Atalay S, Bilirer KK. Systemic Immune-inflammatory Index and platelet-to-lymphocyte ratio in intrahepatic cholestasis of pregnancy. Saudi Med J. 2024;45(11):1217-1222. doi:10.15537/SMJ.2024.45.11.20240760
  2. Mathur D, Morgan M, McKenzie J, Wakefield D, Janicki MB, Figueroa R. Intrahepatic cholestasis of pregnancy: dilemma in diagnosis and management. J Matern Fetal Neonatal Med. 2022;35(25):8975-8981. doi:10.1080/14767058.2021.2008896
  3. İpek G, Tanaçan A, Peker A, Ağaoğlu Z, Kara Ö, Şahin D. Systemic Inflammation Response Index as a diagnostic and prognostic predictor of intrahepatic cholestasis of pregnancy: a case–control study from a tertiary center. Int J Gynecol Obstet. 2024;165(2):717-722. doi:10.1002/ijgo.15216
  4. Oztas E, Erkenekli K, Ozler S, et al. Can routine laboratory parameters predict adverse pregnancy outcomes in intrahepatic cholestasis of pregnancy? J Perinat Med. 2015;43(6):667-674. doi:10.1515/jpm-2014-0207
  5. Özkan S, Aksan A, Kurt D, et al. Are Systemic inflammation markers reliable for diagnosing intrahepatic cholestasis of pregnancy? A retrospective cohort study. Am J Reprod Immunol. 2024;92(4):e13937. doi:10.1111/aji.13937
  6. Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014;124(1):120-133. doi:10.1097/AOG.0000000000000346
  7. McIlvride S, Dixon PH, Williamson C. Bile acids and gestation. Mol Aspects Med. 2017;56:90-100. doi:10.1016/j.mam.2017.05.003
  8. Abide ÇY, Vural F, Kılıççı Ç, et al. Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? Turk J Obstet Gynecol. 2017;14(3):160-165. doi:10.4274/tjod.67674
  9. Silva J, Magenta M, Sisti G, Serventi L, Gaither K. Association between complete blood count components and intrahepatic cholestasis of pregnancy. Cureus. 2020;12(12):8-13. doi:10.7759/cureus.12381
  10. Ergani SY, Celen S. Role of Systemic Immune-inflammatory Index to predict intrahepatic cholestasis of pregnancy. Clin Lab. 2024;70(3):555-561. doi:10.7754/Clin.Lab.2023.231211
  11. Gao XX, Ye MY, Liu Y, et al. Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a Chinese population. Sci Rep. 2020;10(1): 16307. doi:10.1038/s41598-020-73378-5
  12. Gok K, Takmaz T, Kose O, et al. Can first-trimester aspartate aminotransferase/platelet ratio index score predict intrahepatic cholestasis of pregnancy? Hepatol Forum. 2023;4(1):30-34. doi:10.14744/hf.2022.2022.0031
  13. Jafarei RM, Moramezi F, Kargarzadeh E, et al. Maternal and fetal outcomes in mothers with intrahepatic cholestasis of pregnancy compared to healthy pregnant women: a case-control study. Shiraz E-Med J 2025 26:12. 2025;26(12):e163163. doi:10.5812/semj-163163
  14. Li P, Jiang Y, Xie M, et l-al. Factors associated with intrahepatic cholestasis of pregnancy and its influence on maternal and infant outcomes. Medicine. 2023;102(1):E32586. doi:10.1097/MD.0000000000032586
  15. Shan D, Dong R, Hu Y. Current understanding of autophagy in intrahepatic cholestasis of pregnancy. Placenta. 2021;115(20):53-59. doi:10.1016/j.placenta.2021.09.014
  16. Chen L, Li J, You Y, et al. Secreted proteins in plasma and placenta as novel non-invasive biomarkers for intrahepatic cholestasis of pregnancy: a case-control study. Heliyon. 2023;9(11):e21616. doi:10.1016/j.heliyon.2023.e21616
  17. Luo M, Wang L, Yao H, et al. Diagnostic and prognostic value of blood inflammation and biochemical indicators for intrahepatic cholestasis of pregnancy in Chinese pregnant women. Sci Rep. 2022;12(1):1-9. doi:10.1038/s41598-022-22199-9
  18. Biberoglu E, Kirbas A, Daglar K, et al. Role of inflammation in intrahepatic cholestasis of pregnancy. J Obstet Gynaecol Res. 2016;42(3): 252-257. doi:10.1111/jog.12902
  19. Allen K, Jaeschke H, Copple BL. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol. 2011;178(1):175-186. doi:10.1016/j.ajpath.2010.11.026
  20. Kebapcilar AG, Taner CE, Kebapcilar L, Bozkaya G. High mean platelet volume, low-grade systemic coagulation, and fibrinolytic activation are associated with pre-term delivery and low APGAR score in intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2010;23(10):1205-1210. doi:10.3109/14767051003653278
  21. Kirbas A, Biberoglu E, Daglar K, et al. Neutrophil-to-lymphocyte ratio as a diagnostic marker of intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2014;180(1):12-15. doi:10.1016/j.ejogrb.2014.05.042
  22. Liu H, Zhang L, Luo X, Li J, Huang S, Qi H. Prediction of late-onset fetal growth restriction by umbilical artery velocities at 37 weeks of gestation: a cross-sectional study. BMJ Open. 2022;12(8):e060620. doi:10.1136/BMJOPEN-2021-060620
  23. Qi Q, Zhuang L, Shen Y, et al. A novel Systemic Inflammation Response Index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158-2167. doi:10.1002/cncr.30057
  24. Hrubaru I, Motoc A, Moise ML, et al. The predictive role of maternal biological markers and inflammatory scores NLR, PLR, MLR, SII, and SIRI for the risk of preterm delivery. J Clin Med. 2022;11(23):6982. doi:10.3390/jcm11236982
  25. Fang J, Lin Y, Chen Z, Lin Y, Pan M. The association of inflammatory markers with maternal-neonatal outcome after cervical cerclage. J Inflamm Res. 2023;16:245-255. doi:10.2147/JIR.S393666
  26. Zhang Y, Yue Y, Sun Z, et al. Pan-Immune-Inflammation Value and its association with all-cause and cause-specific mortality in the general population: a nationwide cohort study. Front Endocrinol (Lausanne). 2025;16:1534018. doi:10.3389/fendo.2025.1534018
  27. Yin S, Wan H, Zhang Y, Zhu M, Wang Z, Cui Z. Pan-Immune-Inflammation Value and risk of hypertensive disorders of pregnancy: a cross-sectional study. J Inflamm Res. 2025;18:8049-8063. doi:10.2147/JIR.S533109
  28. Jiang R, Hua Y, Hu X, Hong Z. The Pan Immune Inflammatory Value in relation to non-alcoholic fatty liver disease and hepatic fibrosis. Clin Res Hepatol Gastroenterol. 2024;48(7):102393. doi:10.1016/j.clinre.2024.102393
  29. Dereli ML, Sucu S, Kurt DS, et al. Systemic Immune Inflammation Index, Systemic Inflammatory Response Index and Pan-Immune Inflammation Value in the prediction of idiopathic late-onset fetal growth restriction. Cytokine. 2026;198:157081. doi:10.1016/j.cyto.2025.157081
  30. Akay A, Akdaş Reis Y, Yilmaz Ergani S, et al. An assessment of the relationship between fetal growth restriction and maternal serum markers of systemic inflammation (NLR, SIRI, SII, and PIV). Niger J Clin Pract. 2025;28(4):545-551. doi:10.4103/njcp.njcp_530_24
  31. Aktemur G, Çakır BT, Karabay G, et al. Second-trimester inflammatory markers in predicting fetal growth restriction: a retrospective analysis. Am J Reprod Immunol. 2025;93(1):e70047. doi:10.1111/aji.70047
  32. Zhu Y, Zhang Y, Hu W, et al. First-trimester Pan-Immune-Inflammation Value predicts preeclampsia in a dose-dependent linear pattern. BMC Pregnancy Childbirth. 2025;25(1):1250. doi:10.1186/s12884-025-08406-1
  33. Kurt D, Yilmaz A. Inflammatory hematologic indices in intrahepatic cholestasis of pregnancy: a retrospective case-control study focusing on the aggregate Index of Systemic Inflammation. BMC Pregnancy Childbirth. 2026;26(1):366. doi:10.1186/S12884-026-08860
  34. Brenøe JE, van Hoorn EGM, Beck L, et al. Altered placental macrophage numbers and subsets in pregnancies complicated with intrahepatic cholestasis of pregnancy (ICP) compared to healthy pregnancies. Placenta. 2024;153:22-30. doi:10.1016/J.PLACENTA.2024.05.129